The μ-opioid receptor gene and smoking initiation and nicotine dependence

Behavioral and Brain Functions

Volumn 2, Issue , 2006, Pages

  Zhang, Lan ^a,b   Kendler, Kenneth S ^a   Chen, Xiangning ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MU OPIATE RECEPTOR; NICOTINE;

ARTICLE; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG DEPENDENCE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TOBACCO DEPENDENCE;

EID: 33748197818     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-2-28     Document Type: Article

References (35)

1. Graul AI, Prous JR: Executive summary: nicotine addiction. Timely Top Med Cardiovasc Dis 2005, 9:E24.
2. Perkins KA, Benowitz N, Henningfield J, Newhouse P, Pomerleau O, Swan G: Society for Research on Nicotine and Tobacco. Addiction 1996, 91:129-144.
3. Batra V, Patkar AA, Berrettini WH, Weinstein SP, Leone FT: The genetic determinants of smoking. Chest 2003, 123:1730-1739.
4. Sullivan PF, Kendler KS: The genetic epidemiology of smoking. Nicotine Tob Res 1999, 1(Suppl 2):S51-S57.
5. Contet C, Kieffer BL, Befort K: Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 2004, 14:370-378.
6. Pomerleau OF: Endogenous opioids and smoking: a review of progress and problems. Psychoneuroendocrinology 1998, 23:115-130.
7. Berrendero F, Kieffer BL, Maldonado R: Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 2002, 22:10935-10940.
8. Kieffer BL, Gaveriaux-Ruff C: Exploring the opioid system by gene knockout. Prog Neurobiol 2002, 66:285-306.
9. Byars JA, Frost-Pineda K, Jacobs WS, Gold MS: Naltrexone augments the effects of nicotine replacement therapy in female smokers. J Addict Dis 2005, 24:49-60.
10. Lerman C, Patterson F, Berrettini W: Treating tobacco dependence: state of the science and new directions. J Clin Oncol 2005, 23:311-323.
11. Covey LS, Glassman AH, Stetner F: Naltrexone effects on short-term and long-term smoking cessation. J Addict Dis 1999, 18:31-40.
12. Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, et al.: The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J 2004.
13. Straub RE, Sullivan PF, Ma Y, Myakishev MV, Harris-Kerr C, Wormley B, Kadambi B, Sadek H, Silverman MA, Webb BT, et al.: Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 16 merit further study. Mol Psychiatry 1999, 4:129-144.
14. Crowley JJ, Oslin DW, Patkar AA Gottheil E, DeMaria PA Jr, O'Brien CP, Berrettini WH, Grice DE: A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet 2003, 13:169-173.
15. Luo X, Kranzler HR, Zhao H, Gelernter J: Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Neuropsychiatr Genet 2003, 120:97-108.
16. Schinka JA, Town T, Abdullah L, Crawford FC, Ordorica PI, Francis E, Hughes P, Graves AB, Mortimer JA, Mullan M: A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry 2002, 7:224-228.
17. Gelernter J, Kranzler H, Cubells J: Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry 1999, 4:476-483.
18. Kranzler HR, Gelernter J, O'Malley S, Hernandez-Avila CA, Kaufman D: Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). Alcohol Clin Exp Res 1998, 22:1359-1362.
19. Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E, Zvartau E, Gelernter J: Association between two {micro}-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 2006, 15:807-819.
20. Prescott CA, Kendler KS: Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 1999, 156:34-40.
21. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA: A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 1999, 29:299-308.
22. Fagerstrom KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978, 3:235-241.
23. Maes HH, Sullivan PF, Bulik CM, Neale MC, Prescott CA, Eaves LJ, Kendler KS: A twin study of genetic and environmental influences n tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med 2004, 34:1251-1261.
24. Silverman MA, Neale MC, Sullivan PF, Harris-Kerr C, Wormley B, Sadek H, Ma Y, Kendler KS, Straub RE: Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence. Am J Med Genet 2000, 96:646-653.
25. HapMap Database [http://www.Hapmap.org]
26. SNPbrowser software [http://www.allsnps.com]
27. Livak KJ: Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anol 1999, 14:143-149.
28. van den Oord EJ, Jiang Y, Riley BP, Kendler KS, Chen X: FP-TDI SNP scoring by manual and statistical procedures: a study of error rates and types. Biotechniques 2003, 34:610-20.
29. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
30. Dudbridge F: Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003, 25:115-121.
31. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, et al.: Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998, 95:9608-9613.
32. Ikeda K, Ide S, Han W, Hayashida M, Uhl GR, Sora I: How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci 2005, 26:311-317.
33. Arias A, Feinn R, Kranzler HR: Association of an Asn40Asp (AII8G) polymorphism in the mu-opioid receptor gene with substance dependence: A meta-analysis. Drug Alcohol Depend 2005.
34. Hoh J, Wille A, Ott J: Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res 2001, 11:2115-2119.
35. Wittke-Thompson JK, Pluzhnikov A, Cox NJ: Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76:967-986.